AstraZeneca strikes $1 billion deal for rare-disease drug maker

AstraZeneca on Thursday struck a $1 billion deal to buy a maker of drug for rare diseases, further building out the capabilities it acquired in the 2021 deal for Alexion Pharmaceuticals.
Article Attribution | Read More at Article Source
[mwai_chat context=”Let’s have a discussion about this article:nnAstraZeneca on Thursday struck a $1 billion deal to buy a maker of drug for rare diseases, further building out the capabilities it acquired in the 2021 deal for Alexion Pharmaceuticals.